Your search returned 83 studies:
- Computer Based Intervention for Type 2 Diabetes in Youth
Conditions: Diabetes Mellitus, Type 2
Location: Houston, Texas
- Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes
Conditions: Pregnancy Complications
Location: Houston, Texas
- Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes
Conditions: Pregnancy Complications
Location: Houston, Texas
- A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
Conditions: Pediatrics - Type 1 Diabetes Mellitus - Type 2 Diabetes Mellitus
Location: Houston, Texas
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
Conditions: Diabetes Mellitus, Type 2 - Heart Failure, Diastolic
Location: Houston, Texas
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Houston, Texas
- A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours
Conditions: Diabetes
Location: Houston, Texas
- Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus
Location: Houston, Texas
- Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus
Location: Katy, Texas
- Metformin Postpartum for GDM
Conditions: Diabetes, Gestational
Location: Houston, Texas
- Metformin Postpartum for GDM
Conditions: Diabetes, Gestational
Location: Houston, Texas
- Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke - Myocardial Infarction - Diabetes
Location: Houston, Texas
- A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
Conditions: Type 2 Diabetes Mellitus
Location: Bellaire, Texas
- Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)
Conditions: Gestational Diabetes Mellitus
Location: Galveston, Texas
- Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Humble, Texas
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Humble, Texas
- Efficacy and Safety Trial of Intravitreal Injections Combined With PRP for the Treatment of CSME Secondary to Diabetes Mellitus (DAVE)
Conditions: Diabetic Macular Edema
Location: Houston, Texas
- Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Houston, Texas
- Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
Conditions: Diabetes - Immunosuppression
Location: Galveston, Texas
- A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus
Location: Katy, Texas
- A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
Conditions: Type 1 Diabetes
Location: Houston, Texas
- A Pilot Study to Identify the Differences in Adipose Tissue Function After Restoring Normal Glycemic Control Following Pancreas Transplantation
Conditions: Diabetes Mellitus, Type 2 - Diabetes Mellitus, Type 1 - End Stage Renal Disease
Location: Galveston, Texas
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Houston, Texas
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Richmond, Texas
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Sugarland, Texas
- Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
Conditions: Acute Ischemic Stroke - Diabetes - Hyperglycemia
Location: Houston, Texas
- Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
Conditions: Acute Ischemic Stroke - Diabetes - Hyperglycemia
Location: Houston, Texas
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Conditions: Cardiovascular Disease - Diabetes Mellitus, Type 2
Location: Houston, Texas
- An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2
Location: Houston, Texas
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Houston, Texas
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Houston, Texas
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Tomball, Texas
- Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-04
Conditions: Diabetes Mellitus - Type 2 Diabetes
Location: Houston, Texas
- A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Conditions: Diabetes Mellitus, Type 2
Location: Houston, Texas
- Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Sugar Land, Texas
- Behavioral Activation Therapy for Rural Veterans With Diabetes and Depression
Conditions: Diabetes Mellitus - Depression
Location: Houston, Texas
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidn
Conditions: Type 2 Diabetes - Chronic Kidney Disease
Location: Houston, Texas
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2
Location: Houston, Texas
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Typ
Conditions: Diabetes Type 2
Location: Houston, Texas
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Typ
Conditions: Diabetes Type 2
Location: Houston, Texas
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Typ
Conditions: Diabetes Type 2
Location: Katy, Texas
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Houston, Texas
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Houston, Texas
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Sugar Land, Texas
- A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control
Conditions: Type 2 Diabetes Mellitus
Location: Sugar Land, Texas
- A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control
Conditions: Type 2 Diabetes Mellitus
Location: Sugar Land, Texas
- A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019 AM3)
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019 AM3)
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM5)
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM5)
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM5)
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM5)
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Ne
Conditions: Diabetic Nephropathy
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Sealy, Texas
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2
Conditions: Type 2 Diabetes Mellitus
Location: Sugar Land, Texas
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Houston, Texas
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Houston, Texas
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Houston, Texas
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Conditions: Cardiovascular Disease, Diabetes Mellitus, Type 2
Location: Kingwood, Texas
- Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
Conditions: Type 2 Diabetes
Location: Houston, Texas
- A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequat
Conditions: Type 2 Diabetes Mellitus
Location: Houston, Texas
- A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequat
Conditions: Type 2 Diabetes Mellitus
Location: Katy, Texas
- A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequat
Conditions: Type 2 Diabetes Mellitus
Location: Sugar Land, Texas
- The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
Conditions: Hyperglycemia - Diabetes Mellitus
Location: Houston, Texas
- A Study of the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-31
Conditions: Diabetes Mellitus
Location: Houston, Texas
|